Saltar al contenido
PivotalWire
Viernes 2 oct 2026SEC · NASDAQ biomédico

Calendario›BIIB›ASPECT

ASPECT

Avonex PEN Satisfaction and Patients Experience Clinical Trial

Ensayo de BIOGEN INC. en Esclerosis multiple.

Más ensayos de: Esclerosis múltiple.

Fase
no aplica
Estado
Completado
Participantes
89
previstos
Centros
10
Fin del objetivo primario
may 2012
fecha real

Qué significa cada fase y cada estado.

Estudio observacional. Comenzó en jun 2011.

Qué mide

Patient satisfaction (del registro, en inglés) (2 meses)

Cómo lo describe el promotor

En el documentoEn inglés, del registroThis is an open-label, multicenter, survey-based study to determine subject satisfaction with using the single-use autoinjector for the delivery of AVONEX PS. Enrollment will consist of 200 subjects in a single cohort who have been prescribed AVONEX PEN in accord with its Product Monograph. All subjects must be experienced AVONEX PS users (i.e., using it for at least 12 weeks without any support person to help with the injections administered in the vastus lateralis) and enrolled in MS AllianceTM program (hereinafter, MS Alliance). The clinic nurse investigator will instruct the patient on the correct method of using AVONEX PEN and the first injection with Autoinjector, using the subject's own supply, will be completed in the clinic, with the clinic nurse investigator present. All further injections of AVONEX PEN will be self-administered at home. The subjects will complete the first set of questionnaires, including Subject Satisfaction Questionnaire, Ease of Use Grading Scale and the Autoinjector Instructions Grading Scale, within 10 minutes after the first injection at the clinic, and will be given another set of questionnaires to be completed at home within 10 minutes following the last study injection 2 months later, provided the subjects still continue to self-administer their AVONEX PEN. The first set of questionnaires will be left with the clinic nurse investigator to be sent to the CRO by fax or e-mail, while the second set will need to be mailed to the CRO by study subjects using the provided self-addressed, postage-paid envelope.

Más ensayos de BIIB

EnsayoFaseEstadoLectura de resultados
Diranersen · CELIAFase 2En marcha, sin reclutarmar 2026 (real)
BIIB142Fase 1Reclutando pacientesago 2026 (prevista, ya pasada: sin actualizar en el registro)
Litifilimab · TOPAZ-2Fase 3En marcha, sin reclutarsep 2026 (prevista, ya pasada: sin actualizar en el registro)
Litifilimab · TOPAZ-1Fase 3En marcha, sin reclutarsep 2026 (prevista, ya pasada: sin actualizar en el registro)
Litifilimab · AMETHYSTFase 2/3En marcha, sin reclutaroct 2026 (prevista)
Natalizumabno aplicaEn marcha, sin reclutaroct 2026 (prevista)

Todos los de BIIB, en su ficha.

Ficha completa en ClinicalTrials.gov (NCT01366040), actualizada en sep 2013.